Open Access | Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice
Development of a vaccine that targets blood-stage malaria parasites is imperative if we are to sustainably reduce the morbidity and mortality caused by this infection.